Clarivate
CLVT | NYSE
$2.29
-$0.04 (-1.72%)
At close: Nov 16, 2026, 4:00 PM ET
$2.29
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:01 PM ET
Clarivate Company Profile
Company profile explainedCompany Profile
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
Key Executives
| Name | Position |
|---|---|
| Matitiahu Shem Tov | Chief Executive Officer & Director |
| Michael Easton | Executive Vice President & Chief Financial Officer |
| William E. Graff | Executive Vice President & Chief Information Officer |
| Bar Veinstein | President of Academia & Government |
| Darien Krimmert | Senior Vice President & Head of People |
| Gwenan White | Senior Vice President of Communications & Brand |
| Henry Levy | President of Life Sciences & Healthcare |
| John Doulamis | Senior Vice President & General Counsel |
| Mark J. Donohue | Head of Investor Relations |
| Maroun S. Mourad | Advisor |
| Matthew Lisowski | Senior VP & Chief Accounting Officer |
| Richard C. Finch | Senior Vice President of Life Sciences and Healthcare |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 13, 2026 | 8-K/A | [Amend] Current Report |
| Oct 08, 2026 | 4 | Filing |
| Oct 06, 2026 | 8-K | Current Report |
| Oct 02, 2026 | 4 | Filing |
| Oct 02, 2026 | 4 | Filing |
| Oct 02, 2026 | 4 | Filing |
| Sep 24, 2026 | 8-K | Current Report |
| Sep 23, 2026 | 8-K | Current Report |
| Sep 17, 2026 | 8-K | Current Report |
| Aug 18, 2026 | 4 | Filing |
Clarivate
| Country | United Kingdom |
| IPO Date | Oct 29, 2018 |
| Industry | Information Technology Services |
| Sector | Technology |
| Employees | 12,000 |
| CEO | Matitiahu Shem Tov |
Contact Details
70 St. Mary Axe London,
GL EC3A 8BE United Kingdom
Stock Details
| Ticker Symbol | CLVT |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001764046 |
| CUSIP Number | G21810109 |
| ISIN Number | JE00BJJN4441 |
| SIC Code | 7374 |
Recent News
- 4 days ago / prnewswire.comClarivate Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities
- 5 days ago / prnewswire.comClarivate to Present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference on November 18
- 5 days ago / prnewswire.comClarivate's IPOne Connects Trusted Patent, Trademark and Litigation Intelligence to Claude
- 6 days ago / prnewswire.comClarivate Announces Pricing Terms of Offers to Purchase for Cash Certain of its Outstanding Debt Securities
- 10 days ago / seekingalpha.comClarivate PLC: Return Of Organic Growth Confirms Speculative Appeal
- 13 days ago / prnewswire.comClarivate Commences Offers to Purchase for Cash Certain of its Outstanding Debt Securities
- 13 days ago / marketbeat.comWhat Clarivate (CLVT) Said on Its Q3 Earnings Call
- 14 days ago / seekingalpha.comClarivate Plc (CLVT) Q3 2026 Earnings Call Transcript
- 14 days ago / zacks.comClarivate PLC (CLVT) Beats Q3 Earnings Estimates
- 14 days ago / prnewswire.comClarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation
Add to Watchlist
Select watchlists to add or remove CLVT